The present disclosure is directed generally to gadolinium nanoparticle conjugates, such as gold/gadolinium or iodine/gadolinium nanoparticle conjugates, nanoparticle conjugates including polymers, nanoparticle conjugates conjugated to targeting agents and pH responsive polymers, and their use in targeting, characterizing and/or imaging disease states in a patient.
